Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression ; volume:11 ; number:1 ; day:27 ; month:3 ; year:2019 ; pages:1-19 ; date:12.2019
Clinical epigenetics ; 11, Heft 1 (27.3.2019), 1-19, 12.2019
- Creator
-
Kamdar, Shivani
Isserlin, Ruth
Kwast, Theodorus Van der
Zlotta, Alexandre R.
Bader, Gary D.
Fleshner, Neil E.
Bapat, Bharati
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-019-0651-z
- URN
-
urn:nbn:de:101:1-2019041823214675924381
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kamdar, Shivani
- Isserlin, Ruth
- Kwast, Theodorus Van der
- Zlotta, Alexandre R.
- Bader, Gary D.
- Fleshner, Neil E.
- Bapat, Bharati
- SpringerLink (Online service)
Other Objects (12)
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
DNA methylation reprogramming of functional elements during mammalian embryonic development
METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
Intermittent high-fat diet: atherosclerosis progression by neutrophil reprogramming
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer
Lipid metabolism reprogramming and its potential targets in cancer
Reprogramming of DNA methylation is linked to successful human preimplantation development
Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression
Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
DNA methylation reprogramming of functional elements during mammalian embryonic development
METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
Intermittent high-fat diet: atherosclerosis progression by neutrophil reprogramming
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer
Lipid metabolism reprogramming and its potential targets in cancer
Reprogramming of DNA methylation is linked to successful human preimplantation development
Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression
Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
DNA methylation reprogramming of functional elements during mammalian embryonic development
METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
Intermittent high-fat diet: atherosclerosis progression by neutrophil reprogramming
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer
Lipid metabolism reprogramming and its potential targets in cancer
Reprogramming of DNA methylation is linked to successful human preimplantation development
Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression
Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression